ATA19362001A - Nukleinsäure bindende peptide und die verwendung derartiger peptide in pharmazeutischen präparaten - Google Patents

Nukleinsäure bindende peptide und die verwendung derartiger peptide in pharmazeutischen präparaten

Info

Publication number
ATA19362001A
ATA19362001A AT0193601A AT19362001A ATA19362001A AT A19362001 A ATA19362001 A AT A19362001A AT 0193601 A AT0193601 A AT 0193601A AT 19362001 A AT19362001 A AT 19362001A AT A19362001 A ATA19362001 A AT A19362001A
Authority
AT
Austria
Prior art keywords
peptides
nucleic acid
pharmaceutical preparations
acid binding
binding peptides
Prior art date
Application number
AT0193601A
Other languages
English (en)
Other versions
AT410666B (de
Original Assignee
Intercell Biomedizinische Forschungs & Entwicklungs Gmbh
Cistem Biotechnologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intercell Biomedizinische Forschungs & Entwicklungs Gmbh, Cistem Biotechnologies Gmbh filed Critical Intercell Biomedizinische Forschungs & Entwicklungs Gmbh
Priority to AT0193601A priority Critical patent/AT410666B/de
Priority to ZA200208348A priority patent/ZA200208348B/xx
Publication of ATA19362001A publication Critical patent/ATA19362001A/de
Application granted granted Critical
Publication of AT410666B publication Critical patent/AT410666B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT0193601A 2001-12-11 2001-12-11 Nukleinsäure bindende peptide und die verwendung derartiger peptide in pharmazeutischen präparaten AT410666B (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AT0193601A AT410666B (de) 2001-12-11 2001-12-11 Nukleinsäure bindende peptide und die verwendung derartiger peptide in pharmazeutischen präparaten
ZA200208348A ZA200208348B (en) 2001-12-11 2002-10-16 Nucleic acid binding peptides and the use of such peptides in pharmaceutical preparations.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0193601A AT410666B (de) 2001-12-11 2001-12-11 Nukleinsäure bindende peptide und die verwendung derartiger peptide in pharmazeutischen präparaten

Publications (2)

Publication Number Publication Date
ATA19362001A true ATA19362001A (de) 2002-11-15
AT410666B AT410666B (de) 2003-06-25

Family

ID=3689369

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0193601A AT410666B (de) 2001-12-11 2001-12-11 Nukleinsäure bindende peptide und die verwendung derartiger peptide in pharmazeutischen präparaten

Country Status (2)

Country Link
AT (1) AT410666B (de)
ZA (1) ZA200208348B (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6942866B2 (en) * 2000-08-16 2005-09-13 Apovia, Inc. Malaria immunogen and vaccine
US20030138769A1 (en) * 2000-08-16 2003-07-24 Birkett Ashley J. Immunogenic HBc chimer particles having enhanced stability

Also Published As

Publication number Publication date
AT410666B (de) 2003-06-25
ZA200208348B (en) 2003-05-15

Similar Documents

Publication Publication Date Title
IL161268A0 (en) Nucleic acid and corresponding protein entitled 161p2f10b and pharmaceutical and diagnostic compositions containing the same
IL233223A (en) Pharmaceutical and diagnostic compositions containing nucleic acids and corresponding proteins entitled 282p1g3
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
IL217317A0 (en) Nucleic acid and corresponding protein entitled 161p2f10b and pharmaceutical and diagnostic compositions containing the same and uses thereof
AU2002365404A8 (en) Solid-phase immobilization of proteins and peptides
EP1462455A4 (de) Neue peptide und deren medizinische verwendungen
EP1414847A4 (de) Isolierte sezernierte humanproteine, sezernierte humanproteine codierende nukleinsäuremoleküle sowie verwendungen davon
EP1414844A4 (de) Isolierte humane sezernierte proteine, nukleinsäuremoleküle, die humane sezernierte proteine codieren, und deren verwendungen
IL158293A0 (en) Nucleic acid and corresponding protein entitled 158p3d2 and pharmaceutical compositions containing the same
IL158860A0 (en) Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer and pharmaceutical compositions containing the same
EE200200353A (et) Inimese heparanaasisarnane polüpeptiid ja nukleiinhape
ATA19362001A (de) Nukleinsäure bindende peptide und die verwendung derartiger peptide in pharmazeutischen präparaten
NO20005547D0 (no) Myelinbasiske proteinpeptider og anvendelser derav
EP1411964A4 (de) Die blutgerinnung modulierende peptide und ihre verwendungszwecke
IL164326A0 (en) Nucleic acid and corresponding protein entitled 238p1b2 and pharmaceutical compositions containing the same
IL160651A (en) Nucleic acid and corresponding protein entitled 205pib5 and pharmaceutical compositions containing the same and uses thereof
ATE456573T1 (de) Nmb0928-protein und dessen verwendung in pharmazeutischen formulierungen
AU2002245311A8 (en) Human protein kinase n-like polypeptide and uses thereof
EP1409004A4 (de) Isolierte menschliche, ras-ähnliche proteine, diese menschlichen, ras-ähnlichen proteine codierende nukleinsäuremoleküle sowie verwendungen davon
EP1234032A4 (de) Nukleinsäure und polypeptid
AU2003217864A8 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
EP1419251A4 (de) Isolierte menschliche transporterproteine, menschliche transporterproteine codierende nukleinsäuremoleküle sowie verwendungen davon
AU2002214669A1 (en) Isolated human transporter proteins nucleic acids and use thereof
EP1379553A4 (de) Isolierte humane ras-ähnliche proteine, nukleinsäurenmoleküle, die für diese humanen ras-ähnlichen proteine kodieren, und deren verwendung
AU2002357145A8 (en) Therapeutic protein and nucleic acid

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee